Clinical Trials Sponsored by 1Globe Biomedical Co., Ltd.

Total 114 results

1Globe Biomedical Co., Ltd.

Recruiting

Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD

NAFLD | NASH

China
1Globe Health Institute LLC

Recruiting

A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer

Metastatic Pancreatic Cancer

Spain, China, France
1Globe Health Institute LLC

Unknown

A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer

Previously Treated Metastatic Colorectal Cancer

China
Next Biomedical Co., Ltd.

Recruiting

SHEPHERD(SHort-acting Embolization Particles for Patients With HEpatocellular Carcinoma Treated by RaDioembolization)

Hepatocellular Carcinoma

Korea, Republic of
Next Biomedical Co., Ltd.

Recruiting

Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Chronic Pain in Elbow or Wrist

Osteoarthritis

Korea, Republic of
Sigknow Biomedical Co., Ltd.

Recruiting

An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients

Atrial Fibrillation | Embolic Stroke of Undetermined Source

Taiwan
MegaPro Biomedical Co. Ltd.

Recruiting

Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors

Solid Tumor, Unspecified, Adult

Taiwan
Next Biomedical Co., Ltd.

Completed

Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere

Uterine Fibroid | Uterine Myoma

Korea, Republic of
Next Biomedical Co., Ltd.

Completed

UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD

Upper Gastrointestinal Bleeding

Korea, Republic of
MegaPro Biomedical Co. Ltd.

Terminated

A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia

Iron Deficiency Anemia

United States
MegaPro Biomedical Co. Ltd.

Completed

The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma

Magnetic Resonance Imaging

Taiwan
MegaPro Biomedical Co. Ltd.

Completed

Phase I , MTD, Pharmacokinetic, Safety/Tolerability, Efficacy of IOP Injection for MRI in Healthy Subjects

Magnetic Resonance Imaging

Taiwan
Next Biomedical Co., Ltd.

Recruiting

Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Knee Degenerative Osteoarthritis

Osteoarthritis

Korea, Republic of
Next Biomedical Co., Ltd.

Recruiting

Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Korea, Republic of
Energenesis Biomedical Co., Ltd.

Recruiting

A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer

Venous Leg Ulcer

Taiwan
ACRO Biomedical Co. Ltd

Completed

ACRO Biocornea Clinical Trial in Taiwan

Corneal Ulcer

Taiwan
Energenesis Biomedical Co., Ltd.

Recruiting

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Diabetes Mellitus | Foot Ulcer | Diabetic Foot Ulcer | Wound

United States
Next Biomedical Co., Ltd.

Completed

Effectiveness of 'Nexpowder' for Hemostatic Treatments of Nonvariceal, Upper Gastrointestinal Bleeding

Nonvariceal Upper Gastrointestinal Bleeding

Korea, Republic of
Next Biomedical Co., Ltd.

Completed

Effectiveness and Safety of Nexpowder as an Endoscopic Hemostatic Treatment

GastroIntestinal Bleeding

Korea, Republic of
MegaPro Biomedical Co. Ltd.

Completed

Phase Ib, Administration the IOP Injection for MRI Contrast Agent in Healthy Subjects

Magnetic Resonance Imaging

Taiwan
Sigknow Biomedical Co., Ltd.

Unknown

Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO

Atrial Fibrillation | Arrhythmias, Cardiac

Taiwan
Original BioMedicals Co. Ltd.

Unknown

A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers

Acute Radiation Syndrome

United States
Taizhou Hanzhong biomedical co. LTD

Recruiting

Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Bladder Cancer

China
Nanjing Yoko Biomedical Co., Ltd.

Recruiting

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Diffuse Large B-Cell Lymphoma, Unspecified Site

China
Beijing Doing Biomedical Co., Ltd.

Not yet recruiting

Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL

Lymphoma | Leukemia

China
Nanjing Yoko Biomedical Co., Ltd.

Suspended

Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke

Acute Ischemic Stroke

China
Nanjing Yoko Biomedical Co., Ltd.

Completed

Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection

Pharmacokinetics

China
Taizhou Hanzhong biomedical co. LTD

Unknown

Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Beijing Doing Biomedical Co., Ltd.

Unknown

Safety and Efficacy of γδ T Cell Against Gastric Cancer

Gastric Cancer

China
BioRegen Biomedical (CHangzhou) Co., Ltd

Completed

The Efficacy of A New Crosslinked Hyaluronan Gel in Prevention of Intrauterine Adhesion

Intrauterine Adhesion
Beijing Doing Biomedical Co., Ltd.

Unknown

Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.

Gastric Cancer

China
Taizhou Hanzhong biomedical co. LTD

Not yet recruiting

A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms

China
Taizhou Hanzhong biomedical co. LTD

Recruiting

HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer

Nonsquamous Non-small Cell Lung Cancer

China
Taizhou HoudeAoke Biomedical Co., Ltd.

Not yet recruiting

Study of LP002 for the Treatment of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma

Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

China
Taizhou Hanzhong biomedical co. LTD

Recruiting

HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer

Stomach Cancer

China
Nanjing Yoko Biomedical Co., Ltd.

Recruiting

Study on Clinical Effectiveness of L-Oxiracetam Injection

Craniocerebral Injury

China
Nanjing Yoko Biomedical Co., Ltd.

Completed

A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

B-Cell Lymphoma

China
Taizhou Hanzhong biomedical co. LTD

Unknown

A Study of HX008 for the Treatment of Patients With Malignant Melanoma

Melanoma

China
Nanjing Yoko Biomedical Co., Ltd.

Unknown

Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies

Hypertensive Emergency

China
Beijing Doing Biomedical Co., Ltd.

Unknown

Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL

Lymphoma | Leukemia

China
Taizhou Hanzhong biomedical co. LTD

Not yet recruiting

A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Beijing Shenogen Biomedical Co., Ltd

Recruiting

Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) (BESTPOP)

Hepatocellular Carcinoma

China
Taizhou Hanzhong biomedical co. LTD

Not yet recruiting

Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC)

Anaplastic Thyroid Cancer

China
Nanjing Yoko Biomedical Co., Ltd.

Completed

Study on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Volunteers

Pharmacokinetics

China
Taizhou Hanzhong biomedical co. LTD

Unknown

A Phase Ib Study of HX008 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Nanjing Yoko Biomedical Co., Ltd.

Completed

Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection

Drug-drug Interaction

China
Taizhou Hanzhong biomedical co. LTD

Active, not recruiting

Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors

Advanced Solid Tumor

China
Taizhou HoudeAoke Biomedical Co., Ltd.

Unknown

A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms

Digestive System Neoplasms

China
Taizhou HoudeAoke Biomedical Co., Ltd.

Unknown

A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma

Melanoma

China
Taizhou Hanzhong biomedical co. LTD

Active, not recruiting

A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer

Triple-negative Breast Cancer

China

3

Subscribe